Kimberly Ferguson

1.7k total citations · 1 hit paper
11 papers, 1.3k citations indexed

About

Kimberly Ferguson is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Kimberly Ferguson has authored 11 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Kimberly Ferguson's work include HIV Research and Treatment (3 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and HIV/AIDS Research and Interventions (2 papers). Kimberly Ferguson is often cited by papers focused on HIV Research and Treatment (3 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and HIV/AIDS Research and Interventions (2 papers). Kimberly Ferguson collaborates with scholars based in United States and Israel. Kimberly Ferguson's co-authors include R Osuna, Reid C. Johnson, Catherine A. Ball, Amy E. Pasquinelli, Sheila A. Homburger, Gary Ruvkun, Jonathan Heller, Darren Platt, Stephen K. Doberstein and Robert G. Wisotzkey and has published in prestigious journals such as Genes & Development, Molecular and Cellular Biology and Journal of Bacteriology.

In The Last Decade

Kimberly Ferguson

11 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family

2001 505 citations Sarah B. Pierce, Michael A. Costa et al. Genes & Development profile →

Peers

Countries citing papers authored by Kimberly Ferguson

Since Specialization

Citations

This map shows the geographic impact of Kimberly Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Ferguson more than expected).

Fields of papers citing papers by Kimberly Ferguson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Ferguson. The network helps show where Kimberly Ferguson may publish in the future.

Co-authorship network of co-authors of Kimberly Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Ferguson. A scholar is included among the top collaborators of Kimberly Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Ferguson. Kimberly Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer 2014 ·Thyroid ·Maria E. Cabanillas, Marcia S. Brose, Jaymes Holland, Kimberly Ferguson, Steven I. Sherman	62
2	A phase I study of cabozantinib (XL184) in patients with renal cell cancer 2014 ·Annals of Oncology ·Toni K. Choueiri, Sumanta K. Pal, David F. McDermott, Shirley Morrissey, Kimberly Ferguson, Jaymes Holland, William G. Kaelin, Janice P. Dutcher	133
3	Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir 2011 ·AIDS ·Deborah Persaud, Katherine Luzuriaga, Carrie Ziemniak, Petronella Muresan, Thomas C. Greenough, Terry Fenton, Amanda L. Blackford, Kimberly Ferguson, Natalie Neu, Coleen K. Cunningham	31
4	Widespread distribution of knockdown resistance mutations in the bed bug, Cimex lectularius (Hemiptera: Cimicidae), populations in the United States 2010 ·Archives of Insect Biochemistry and Physiology ·Fang Zhu, John Wigginton, Álvaro Romero, (unknown), Kimberly Ferguson, (unknown), Michael F. Potter, Kenneth F. Haynes, Subba Reddy Palli	164
5	Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch After Initial Nonsuppressive Highly Active Antiretroviral Therapy 2008 ·AIDS Patient Care and STDs ·Allison L. Agwu, Jane C. Lindsey, Kimberly Ferguson, Haili Zhang, Stephen A. Spector, Bret J. Rudy, Stuart C. Ray, Steven D. Douglas, Patricia M. Flynn, Deborah Persaud	19
6	Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy 2007 ·AIDS Research and Human Retroviruses ·Deborah Persaud, Stuart C. Ray, (unknown), Aima A. Ahonkhai, George K. Siberry, Kimberly Ferguson, Carrie Ziemniak, Thomas C. Quinn, Joseph P. Casazza, Steven L. Zeichner, Stephen J. Gange, Douglas C. Watson	51
7	Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family breakdown → 2001 ·Genes & Development ·Sarah B. Pierce, Michael A. Costa, Robert G. Wisotzkey, (unknown), Sheila A. Homburger, Andrew R. Buchman, Kimberly Ferguson, Jonathan Heller, Darren Platt, Amy E. Pasquinelli, Leo X. Liu, Stephen K. Doberstein, Gary Ruvkun	505
8	Alterations in the Conserved SL1trans-Spliced Leader of Caenorhabditis elegans Demonstrate Flexibility in Length and Sequence Requirements In Vivo 1999 ·Molecular and Cellular Biology ·Kimberly Ferguson, Joel H. Rothman	19
9	The SL1 trans-spliced leader RNA performs an essential embryonic function in Caenorhabditis elegans that can also be supplied by SL2 RNA. 1996 ·Genes & Development ·Kimberly Ferguson, Paul J. Heid, Joel H. Rothman	43
10	Alveolar stem cell transduction by an adeno-associated viral vector. 1995 ·PubMed ·Pamela L. Zeitlin, (unknown), C. Conrad, (unknown), Kimberly Ferguson, Terence R. Flotte, William B. Guggino	21
11	Dramatic changes in Fis levels upon nutrient upshift in Escherichia coli 1992 ·Journal of Bacteriology ·Catherine A. Ball, R Osuna, Kimberly Ferguson, Reid C. Johnson	301

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact